Tamiphar SA
8.6 FTETamiphar reported total assets of €2.46m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Oct 2026), with 8.6 full-time equivalents.
The score of Tamiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -84 % Total assets +5 % Headcount (avg FTE) +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tamiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,311 € | ||||
| Equity | 25,342 € | ||||
| Cash | 100,347 € | ||||
| EBITDA | 127,720 € | ||||
| Total assets | €2.46m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Oct 2026
- Year ended 31 Dec 2024filed on 10 Oct 2025
- Year ended 31 Dec 2023filed on 31 Oct 2024
- Year ended 31 Dec 2022filed on 08 Mar 2024
- Year ended 31 Dec 2021filed on 27 Mar 2023
Tamiphar's financial analysis
- Solvency1.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tamiphar
Tamiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.793.509
- VAT number
- BE0443793509
- Peppol
- Registered · 0208:0443793509 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Mar 1991
- Registered office
- 1380 Lasne
- Size
- Micro · 8.6 FTE
- Latest accounts
- 2025 · filed on 15 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tamiphar (SA) has been based in Lasne since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,311 € and equity of 25,342 €; its revenue is not published. With 8.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 1.0%, below the median of its sector (41.5%).
Companies similar to Tamiphar
Companies in the same business, of comparable size and area, outside its group.
- Abfab Retail sale of pharmaceutical products Anderlecht · balance sheet €2.46m
- De Witte - De Sutter Retail sale of pharmaceutical products Dendermonde · balance sheet €2.45m
- DE BIE T. Retail sale of pharmaceutical products Affligem · balance sheet €2.45m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
- Gobert Sophie Retail sale of pharmaceutical products Bruges · balance sheet €2.48m
- Apotheek VAN DE Mierop - Mestdagh Retail sale of pharmaceutical products Beerse · balance sheet €2.44m
- Pharmadefi Retail sale of pharmaceutical products Arlon · balance sheet €2.48m
- Decon Retail sale of pharmaceutical products Maasmechelen · balance sheet €2.48m
Frequently asked questions about Tamiphar
What is the revenue of Tamiphar?
Tamiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tamiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0443793509 for Tamiphar, if the company is VAT-registered. Its company number (CBE) is 0443.793.509.
Where is the registered office of Tamiphar?
According to the CBE register, the registered office of Tamiphar is in 1380 Lasne.
What is the equity of Tamiphar?
At the close of the 2025 financial year, the equity of Tamiphar amounts to 25,342 €, a solvency of 1.0% of total assets.
How many people work at Tamiphar?
8.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tamiphar?
The register lists 7 active mandates at Tamiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tamiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →